These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3525428)

  • 21. Double-blind, placebo-controlled quantitative EEG and psychometric studies in elderlies on vigilance-promoting effects of an almitrine/raubasine combination (Duxil).
    Saletu B; Grünberger J; Linzmayer L; Anderer P
    Arch Gerontol Geriatr; 1988 Jun; 7(2):93-110. PubMed ID: 3415398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Objective measures in determining the central effectiveness of a new antihypoxidotic SL-76188: pharmaco-EEG, psychometric and pharmacokinetic analyses in the elderly.
    Grünberger J; Saletu B; Linzmayer L; Stöhr H
    Arch Gerontol Geriatr; 1982 Nov; 1(3):261-85. PubMed ID: 6764605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and dynamic studies with a new anxiolytic imidazo-pyridine alpidem utilizing pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L
    Int Clin Psychopharmacol; 1986 Apr; 1(2):145-64. PubMed ID: 2883214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials.
    Saletu B; Grünberger J; Linzmayer L; Anderer P; Semlitsch HV
    Neuropsychobiology; 1990-1991; 24(3):135-48. PubMed ID: 2135068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychophysiological and psychometric studies after manipulating the GABA system by vigabatrin, a GABA-transaminase inhibitor.
    Saletu B; Grünberger J; Linzmayer L; Schwartz JJ; Haegele KD; Schechter PJ
    Int J Psychophysiol; 1986 May; 4(1):63-80. PubMed ID: 3721943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relation between blood levels and average quantitative EEG and psychometrically assessed pharmacodynamic changes following zotepine].
    Saletu B; Grünberger J; Anderer P; Chwatal K
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():45-55. PubMed ID: 1683340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On acute and chronic CNS effects of antidepressants in normals: neurophysiological, behavioral and pharmacokinetic studies with pirlindol.
    Saletu B; Grünberger J
    Methods Find Exp Clin Pharmacol; 1985 Mar; 7(3):137-51. PubMed ID: 4010387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classification and bioavailability studies with WE 941 by quantitative pharmaco-EEG and clinical analyses.
    Saletu B; Grünberger J; Volavka J; Berner P
    Arzneimittelforschung; 1979; 29(4):700-4. PubMed ID: 582772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation.
    Saletu B; Barbanoj MJ; Anderer P; Sieghart W; Grünberger J
    Methods Find Exp Clin Pharmacol; 1993 Jun; 15(5):291-312. PubMed ID: 8412414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
    Saletu B; Anderer P; Wolzt M; Nosiska D; Assandri A; Noseda E; Nannipieri F; Saletu-Zyhlarz GM
    Neuropsychobiology; 2009; 59(2):110-22. PubMed ID: 19365151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophysiology.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; Semlitsch HV; Magni G
    Br J Clin Pharmacol; 1992 Jun; 33(6):589-601. PubMed ID: 1389931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and -inhibiting fluvoxamine utilizing EEG mapping and psychometry.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; Zyhlarz G
    J Neural Transm (Vienna); 1996; 103(1-2):191-216. PubMed ID: 9026373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacodynamic studies on the central mode of action of S-adenosyl-L-methionine (SAMe) infusions in elderly subjects, utilizing EEG mapping and psychometry.
    Saletu B; Anderer P; Linzmayer L; Semlitsch HV; Lindeck-Pozza E; Assandri A; di Padova C; Saletu-Zyhlarz GM
    J Neural Transm (Vienna); 2002 Dec; 109(12):1505-26. PubMed ID: 12486491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visualizing central effects of S-adenosyl-L-methionine (SAMe), a natural molecule with antidepressant properties, by pharmaco-EEG mapping.
    Saletu-Zyhlarz GM; Anderer P; Linzmayer L; Semlitsch HV; Assandri A; Prause W; Hassan Abu-Bakr M; Lindeck-Pozza E; Saletu B
    Int J Neuropsychopharmacol; 2002 Sep; 5(3):199-215. PubMed ID: 12366873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind, placebo-controlled, pharmacokinetic and -dynamic studies with 2 new formulations of piracetam (infusion and sirup) under hypoxia in man.
    Saletu B; Hitzenberger G; Grünberger J; Anderer P; Zyhlarz G; Linzmayer L; Rameis H
    Int J Clin Pharmacol Ther; 1995 May; 33(5):249-62. PubMed ID: 7655763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative bioavailability studies with a new mixed-micelles solution of diazepam utilizing radioreceptor assay, psychometry and EEG brain mapping.
    Saletu B; Anderer P; Kinsperger K; Grünberger J; Sieghart W
    Int Clin Psychopharmacol; 1988 Oct; 3(4):287-323. PubMed ID: 3235816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classification and assessment of cerebral bioavailability of lopirazepam (D-12524) by quantitative EEG and psychometric analysis.
    Saletu B; Grünberger J; Linzmayer L; Stadler R
    Arzneimittelforschung; 1980; 30(3):513-8. PubMed ID: 6104496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment effects of gabapentin for primary insomnia.
    Lo HS; Yang CM; Lo HG; Lee CY; Ting H; Tzang BS
    Clin Neuropharmacol; 2010; 33(2):84-90. PubMed ID: 20124884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmaco-EEG profile of maroxepine: third example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs.
    Herrmann WM; Schärer E; Wendt G; Delini-Stula A
    Pharmacopsychiatry; 1991 Nov; 24(6):214-24. PubMed ID: 1812498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EEG brain mapping in evaluating the time-course of the central action of DUP 996--a new acetylcholine releasing drug.
    Saletu B; Darragh A; Salmon P; Coen R
    Br J Clin Pharmacol; 1989 Jul; 28(1):1-16. PubMed ID: 2775607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.